Restoring Lower Prescription Drug Prices for American Patients

Strategic Insights -

President Trump's executive order aims to restore progress made during his first term to deliver lower prescription drug prices to American patients, which was undone by the Biden Administration. The order calls for various measures to reduce costs, promote competition, and improve innovation in the pharmaceutical industry. This executive order is a response to the Inflation Reduction Act, which the Biden Administration signed into law, and seeks to address its shortcomings.

Key Takeaways:

  • The executive order aims to reduce prescription drug prices by promoting competition, improving transparency, and increasing access to affordable medications.
  • The order proposes to improve the Medicare Drug Price Negotiation Program by prioritizing the selection of prescription drugs with high costs and minimizing negative impacts on pharmaceutical innovation.
  • The Secretary of Health and Human Services will work with Congress to modify the Medicare Drug Price Negotiation Program to align the treatment of small molecule prescription drugs with that of biological products.
  • The order also calls for reducing the prices of high-cost drugs for seniors, promoting innovation, value, and enhanced oversight in Medicaid drug payment, and increasing access to affordable life-saving medications.
  • The order includes measures to reevaluate the role of middlemen, accelerate competition for high-cost prescription drugs, increase prescription drug importation to lower prices, reduce costly care for seniors, and improve transparency into pharmacy benefit manager fee disclosure.

Statistics:

  • The Inflation Reduction Act's Medicare Prescription Drug Negotiation Program has produced much lower savings than projected.
  • The program imposes price controls on small molecule prescription drugs 4 years earlier than on large molecule biological products, which may distort innovation and investment.
  • The Biden Administration's actions have undone progress made during President Trump's first term to deliver lower prescription drug prices to American patients.
  • The executive order aims to reduce prescription drug prices by promoting competition and improving transparency.

Sources:

  • Original text: https://www.whitehouse.gov/presidential-actions/lowering-drug-prices-by-once-again-putting-americans-first/
  • The Inflation Reduction Act (2022)
  • The Medicare Prescription Drug Negotiation Program (2022)
  • Section 1927 of the Social Security Act
  • Section 1833(t)(14)(D)(ii) of the Social Security Act
  • Section 254b(e) of the Public Health Service Act
  • Section 804 of the Federal Food, Drug, and Cosmetic Act
  • Section 408(b)(2)(B) of the Employee Retirement Income Security Act of 1974
  • The Employee Retirement Income Security Act of 1974
  • The Department of Justice
  • The Department of Commerce
  • The Federal Trade Commission